4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS
Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury i...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YOUNG, STEVEN, D BUTCHER, JOHN WHITTER, WILLIE LIVERTON, NIGEL DIECKHAUS, CHRISTINE MUNSON, PETER THOMPSON, WAYNE LAYTON, MARK, E PHILLIPS, BRIAN, T MCCAULEY, JOHN, A SANDERSON, PHILIP, E MCINTYRE, CHARLES, J |
description | Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1656379A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1656379A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1656379A13</originalsourceid><addsrcrecordid>eNrjZLAy0XWOdPbxd_TxjvRx9PX08w-IDHKM8vfxVwAyPH09XTz9XBX8fF0c9f2CjJwUHP1CHN39_TyDQ4J5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4ChmamZsbmlo6ExEUoAnT0pJw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS</title><source>esp@cenet</source><creator>YOUNG, STEVEN, D ; BUTCHER, JOHN ; WHITTER, WILLIE ; LIVERTON, NIGEL ; DIECKHAUS, CHRISTINE ; MUNSON, PETER ; THOMPSON, WAYNE ; LAYTON, MARK, E ; PHILLIPS, BRIAN, T ; MCCAULEY, JOHN, A ; SANDERSON, PHILIP, E ; MCINTYRE, CHARLES, J</creator><creatorcontrib>YOUNG, STEVEN, D ; BUTCHER, JOHN ; WHITTER, WILLIE ; LIVERTON, NIGEL ; DIECKHAUS, CHRISTINE ; MUNSON, PETER ; THOMPSON, WAYNE ; LAYTON, MARK, E ; PHILLIPS, BRIAN, T ; MCCAULEY, JOHN, A ; SANDERSON, PHILIP, E ; MCINTYRE, CHARLES, J</creatorcontrib><description>Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060517&DB=EPODOC&CC=EP&NR=1656379A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060517&DB=EPODOC&CC=EP&NR=1656379A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YOUNG, STEVEN, D</creatorcontrib><creatorcontrib>BUTCHER, JOHN</creatorcontrib><creatorcontrib>WHITTER, WILLIE</creatorcontrib><creatorcontrib>LIVERTON, NIGEL</creatorcontrib><creatorcontrib>DIECKHAUS, CHRISTINE</creatorcontrib><creatorcontrib>MUNSON, PETER</creatorcontrib><creatorcontrib>THOMPSON, WAYNE</creatorcontrib><creatorcontrib>LAYTON, MARK, E</creatorcontrib><creatorcontrib>PHILLIPS, BRIAN, T</creatorcontrib><creatorcontrib>MCCAULEY, JOHN, A</creatorcontrib><creatorcontrib>SANDERSON, PHILIP, E</creatorcontrib><creatorcontrib>MCINTYRE, CHARLES, J</creatorcontrib><title>4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS</title><description>Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAy0XWOdPbxd_TxjvRx9PX08w-IDHKM8vfxVwAyPH09XTz9XBX8fF0c9f2CjJwUHP1CHN39_TyDQ4J5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4ChmamZsbmlo6ExEUoAnT0pJw</recordid><startdate>20060517</startdate><enddate>20060517</enddate><creator>YOUNG, STEVEN, D</creator><creator>BUTCHER, JOHN</creator><creator>WHITTER, WILLIE</creator><creator>LIVERTON, NIGEL</creator><creator>DIECKHAUS, CHRISTINE</creator><creator>MUNSON, PETER</creator><creator>THOMPSON, WAYNE</creator><creator>LAYTON, MARK, E</creator><creator>PHILLIPS, BRIAN, T</creator><creator>MCCAULEY, JOHN, A</creator><creator>SANDERSON, PHILIP, E</creator><creator>MCINTYRE, CHARLES, J</creator><scope>EVB</scope></search><sort><creationdate>20060517</creationdate><title>4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS</title><author>YOUNG, STEVEN, D ; BUTCHER, JOHN ; WHITTER, WILLIE ; LIVERTON, NIGEL ; DIECKHAUS, CHRISTINE ; MUNSON, PETER ; THOMPSON, WAYNE ; LAYTON, MARK, E ; PHILLIPS, BRIAN, T ; MCCAULEY, JOHN, A ; SANDERSON, PHILIP, E ; MCINTYRE, CHARLES, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1656379A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>YOUNG, STEVEN, D</creatorcontrib><creatorcontrib>BUTCHER, JOHN</creatorcontrib><creatorcontrib>WHITTER, WILLIE</creatorcontrib><creatorcontrib>LIVERTON, NIGEL</creatorcontrib><creatorcontrib>DIECKHAUS, CHRISTINE</creatorcontrib><creatorcontrib>MUNSON, PETER</creatorcontrib><creatorcontrib>THOMPSON, WAYNE</creatorcontrib><creatorcontrib>LAYTON, MARK, E</creatorcontrib><creatorcontrib>PHILLIPS, BRIAN, T</creatorcontrib><creatorcontrib>MCCAULEY, JOHN, A</creatorcontrib><creatorcontrib>SANDERSON, PHILIP, E</creatorcontrib><creatorcontrib>MCINTYRE, CHARLES, J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YOUNG, STEVEN, D</au><au>BUTCHER, JOHN</au><au>WHITTER, WILLIE</au><au>LIVERTON, NIGEL</au><au>DIECKHAUS, CHRISTINE</au><au>MUNSON, PETER</au><au>THOMPSON, WAYNE</au><au>LAYTON, MARK, E</au><au>PHILLIPS, BRIAN, T</au><au>MCCAULEY, JOHN, A</au><au>SANDERSON, PHILIP, E</au><au>MCINTYRE, CHARLES, J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS</title><date>2006-05-17</date><risdate>2006</risdate><abstract>Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP1656379A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A14%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YOUNG,%20STEVEN,%20D&rft.date=2006-05-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1656379A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |